Model
Edge
Amylyx Pharmaceuticals Inc.
0001913765
Filing Type
4
Filing Date
3/9/2025
Updated
3/10/25, 6:34 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership